Font Size: |    |
रा्ट्रय औषधय शिक्ा और नुसंधा सं्थान
(रसान और उर्वरक ंत्रालय, भात रकार का औषध विभाग)
NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH
(Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Govt. of India)
logo
Medicinal Chemistry

Dr. Sandeep Chaudhary

Associate Professor


The Department of Medicinal Chemistry offers a two-year M.S. (Pharm.) Med. Chem. program since its inception in 2008. There are currently 17 seats available which are filled through NIPER-JEE conducted every year.

In addition, the Department offers a two-year M.S. (Pharm.) Pharmaceutical Analysis program from session 2024-25. There are currently 10 seats available which are filled through NIPER-JEE conducted every year. The goal of the program of Pharmaceutical Analysis is to focus on the development of analytical techniques for the characterization and quantitation of drug and their formulations. It also entails fundamental investigation into the identification, stability, composition, and purity of excipients, active pharmaceutical ingredients (API), and starting materials. This training will produce skilled postgraduate students in analytical sciences.

The Department of Medicinal Chemistry is actively involved in the drug design research programme which includes multidisciplinary research in various aspects of drug synthesis. Research in medicinal chemistry requires an in-depth knowledge of synthetic chemistry along with focus on information about drug-receptor interactions. The students pursuing M. S. (Pharm.) degree are exposed towards fundamental and practical knowledge of design and synthesis of pharmaceutically active compounds.

The faculty in the department are involved in research focus on identification of novel chemotherapeutic agents for various diseases like cancer, malaria, tuberculosis and other inflammatory diseases.

Programs Offered
M.S. (Pharm.) + -
Ph.D. + -
M.S. (Pharm.) Pharmaceutical Analysis + -

Publication / Research

Research Projects

  • Sep
  • 2023

Synthesis and evaluation of novel dual GSK-3β/HDAC inhibitor as an anti-Alzheimer agent.

Abha Sharma 3791040 Sponsored By: ANRF

  • Dec
  • 2023

To investigate

Abha Sharma 1486000 Sponsored By: CST UP

  • Sep
  • 2021

Novel synthesis of flavonoid-hydroxypyridinone hybrids as potential anti-Alzheimer agents.

Abha Sharma 930000 Sponsored By: CST UP

  • Oct
  • 2024

Exploration of oxadiazole scaffolds into potential pan peroxisome proliferator-activated receptors (PPARs) agonists as antidiabetic agents

Gopal Lal Khatik 4676720 Sponsored By: Anusandhan National Research Foundation (ANRF)

  • Aug
  • 2022

Development of modified kynurenic acid-based scaffolds for treatment of post-traumatic stress disorder

Gopal Lal Khatik 600000 Sponsored By: Council of Science and Technology UP - CSTUP

  • Feb
  • 2022

Designing of senolytic agents for the treatment of Alzheimers disease

Gopal Lal Khatik 3943764 Sponsored By: Science & Engineering Research Board (SERB)

  • Mar
  • 2019

Development of SOPs and Standardization of Different Preparation Techniques of Netra Putapaka Formulation for Ophthalmic Use

Gopal Lal Khatik 0 Sponsored By:

  • Oct
  • 2014

Design, synthesis, and evaluation of novel heterocyclic scaffolds as potential antidiabetic agents targeted to PPAR alpha gamma dual agonist

Gopal Lal Khatik 0 Sponsored By:

  • Feb
  • 2022

Discovering the anti-inflammatory effects of novel Toll-like receptor signaling inhibitors on rheumatoid arthritis mononuclear cells and synovial fibroblasts- An in vitro study to identify TLR signaling inhibition in rheumatoid arthritis

Sandeep Chaudhary 1250000 Sponsored By: ICMR Grant (Adhoc) in collaboration with AIIMS New Delhi (2022-2025)

  • Feb
  • 2020

Exploring the immunomodulatory activities of novel Toll-like receptor-signaling inhibitors in peripheral blood mononuclear cells from lupus patients: A study to identify TLRs as drug targets for lupus

Sandeep Chaudhary 522500 Sponsored By: Core Research Grant (CRG) in collaboration with AIIMS New Delhi (2020-2024)

  • Mar
  • 2019

Aminoglycoside (Tobramycin) Based HybridSmall Molecules Targeting Bacterial rRNA A-site for Developing New AntitubercularAgents

Nihar Ranjan 3593940 Sponsored By: SERB

Lab Instruments

Faculty Members
Photo Gallery
https://niper.vocsecure.com/